Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 220Rectal Neoplasms 137Stomach Neoplasms 95Colonic Neoplasms 87Pancreatic Neoplasms 82Esophageal Neoplasms 71Neoplasm Metastasis 58Squamous Cell Carcinoma of Head and Neck 43Head and Neck Neoplasms 42Adenocarcinoma Of Esophagus 37Neoplasms 36Breast Neoplasms 35Esophageal Squamous Cell Carcinoma 27Carcinoma, Hepatocellular 22Cholangiocarcinoma 21Adenocarcinoma 17Nasopharyngeal Carcinoma 16Bile Duct Neoplasms 14Gallbladder Neoplasms 13Carcinoma, Squamous Cell 13Biliary Tract Neoplasms 13Anus Neoplasms 13Urinary Bladder Neoplasms 11Liver Neoplasms 10Carcinoma 9Nasopharyngeal Neoplasms 8Colorectal Cancer Metastatic 8Peritoneal Neoplasms 7Recurrence 6Ovarian Neoplasms 6

Interventions

pegfilgrastim 13Filgrastim 13Cytarabine 5Cyclophosphamide 5pegylated granulocyte colony-stimulating factor 4Etoposide 4Methotrexate 3Doxorubicin 3Docetaxel 3trifluridine tipiracil drug combination 2Vincristine 2Daunorubicin 2Cisplatin 2Amifostine 2trilaciclib 1niraparib 1lintuzumab 1leridistim 1isavuconazole 1fludarabine phosphate 1fish oil triglycerides 1etoposide phosphate 1eravacycline 1eflapegrastim 1angiotensin I (1-7) 1Voriconazole 1Vegetables 1Topotecan 1Thioguanine 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neutropenia × Fluorouracil × Clear all
NCT00124111 2010-02-26

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Amgen

Phase 2 Completed
Breast

Breast Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡